These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18035195)

  • 21. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
    Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Pharmacokinetic/Pharmacodynamics Modeling of Ibutilide in Chinese Healthy Volunteers and Patients With Atrial Fibrillation (AF) and/or Atrial Flutter (AFL).
    Zeng Z; Wang L; Hua L; Jiang J; Pang H; Huang Y; Li Y; Tian L
    Clin Ther; 2017 Jul; 39(7):1320-1335. PubMed ID: 28624123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiology and pharmacology of ibutilide.
    Naccarelli GV; Lee KS; Gibson JK; VanderLugt J
    Am J Cardiol; 1996 Oct; 78(8A):12-6. PubMed ID: 8903270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
    Zhang Q; Tao Y; Zhu Y; Zhu D
    Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced QT prolongation in women during the menstrual cycle.
    Rodriguez I; Kilborn MJ; Liu XK; Pezzullo JC; Woosley RL
    JAMA; 2001 Mar; 285(10):1322-6. PubMed ID: 11255387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.
    Korantzopoulos P; Kolettis TM; Papathanasiou A; Naka KK; Kolios P; Leontaridis I; Draganigos A; Katsouras CS; Goudevenos JA
    Heart; 2006 May; 92(5):631-4. PubMed ID: 16159973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.
    Buchanan LV; LeMay RJ; Walters RR; Hsu CY; Brunden MN; Gibson JK
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibutilide-induced alterations in electrocardiographic and spatial vectorcardiographic descriptors of ventricular repolarization.
    Dilaveris P; Theoharis A; Giaouris P; Anastasopoulos A; Zumerle B; Tzannetis G; Stefanadis C
    Clin Cardiol; 2004 Jun; 27(6):359-63. PubMed ID: 15237698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteers.
    Yang J; He Y; Du YX; Tang LL; Wang GJ; Fawcett JP
    Clin Ther; 2009 Feb; 31(2):311-20. PubMed ID: 19302903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
    Steinwender C; Hönig S; Kypta A; Kammler J; Schmitt B; Leisch F; Hofmann R
    Int J Cardiol; 2010 Jun; 141(3):260-5. PubMed ID: 19136164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.
    Eidher U; Freihoff F; Kaltenbrunner W; Steinbach K
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):358-62. PubMed ID: 16650262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability.
    Guo GB; Ellenbogen KA; Wood MA; Stambler BS
    J Am Coll Cardiol; 1996 Apr; 27(5):1083-9. PubMed ID: 8609325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
    Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
    Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
    VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR
    Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibutilide: a new class III antiarrhythmic agent.
    Granberry MC
    Am J Health Syst Pharm; 1998 Feb; 55(3):255-60. PubMed ID: 9492255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.